0001562180-22-007835.txt : 20221122
0001562180-22-007835.hdr.sgml : 20221122
20221122182030
ACCESSION NUMBER: 0001562180-22-007835
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20221118
FILED AS OF DATE: 20221122
DATE AS OF CHANGE: 20221122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KUCHERLAPATI RAJU S
CENTRAL INDEX KEY: 0001079537
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39362
FILM NUMBER: 221411799
MAIL ADDRESS:
STREET 1: 77 LOUIS PASTEUR AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GELESIS HOLDINGS, INC.
CENTRAL INDEX KEY: 0001805087
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 844730610
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 BOYLSTON STREET, SUITE 6102
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 857-327-7737
MAIL ADDRESS:
STREET 1: 501 BOYLSTON STREET, SUITE 6102
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: CAPSTAR SPECIAL PURPOSE ACQUISITION CORP.
DATE OF NAME CHANGE: 20200227
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-11-18
false
0001805087
GELESIS HOLDINGS, INC.
GLS
0001079537
KUCHERLAPATI RAJU S
GELESIS HOLDINGS, INC.
501 BOYLSTON STREET, SUITE 6102
BOSTON
MA
02116
true
false
false
false
Common Stock
2022-11-18
2022-11-18
4
P
false
8000.00
0.39
A
98264.00
D
Common Stock
2022-11-21
2022-11-21
4
P
false
92000.00
0.45
A
190264.00
D
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.39. Actual prices ranged from $0.37 to $0.39. The reporting person hereby undertakes to provide upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.45. Actual prices ranged from $0.42 to $0.45. The reporting person hereby undertakes to provide upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Exhibit 24 - Power of Attorney
/s/ Elliot Maltz, Attorney-in-Fact
2022-11-22
EX-24
2
powerofattorney.txt
POA
LIMITED POWER OF ATTORNEY
The undersigned hereby constitutes and appoints each of Elliot Maltz and
Wenlie Zhou, signing singly, and with
full power of substitution, the undersigned's true and lawful attorney-in-
fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's
capacity as officer and/or director of
Gelesis Holdings, Inc., a Delaware corporation (the "Company"), from time
to time the following U.S. Securities and
Exchange Commission ("SEC") forms: (i) Form ID, including any attached
documents (such as Update Passphrase
Authentication), to effect the assignment of codes to the undersigned to
be used in the transmission of information to the
SEC using the EDGAR System; (ii) Form 3, Initial Statement of Beneficial
Ownership of Securities, including any
attached documents; (iii) Form 4, Statement of Changes in Beneficial
Ownership of Securities, including any attached
documents; (iv) Form 5, Annual Statement of Beneficial Ownership of
Securities in accordance with Section 16(a) of the
Securities Exchange Act of 1934, as amended, and the rules thereunder,
including any attached documents; (v) Schedules
13D and 13G; and (vi) amendments of each thereof, in accordance with
the Securities Exchange Act of 1934, as amended,
and the rules thereunder, including any attached documents;
(2) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or
desirable to complete and execute any such Form 3, 4 or 5, Schedule 13D
or 13G, or any amendment(s) thereto and
timely file such form(s) with the SEC and any securities exchange, national
association or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of
such attorney-in-fact, may be of benefit to, in the best interest of, or
legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on
behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain such terms and conditions
as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact, acting
singly, full power and authority to do and
perform any and every act and thing whatsoever requisite, necessary or
proper to be done in the exercise of any of the
rights and powers herein granted, as fully to all intents and purposes as
the undersigned might or could do if personally
present, with full power of substitution or revocation, hereby ratifying and
confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully do or cause
to be done by virtue of this power of attorney
and the rights and powers herein granted. The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving
in such capacity at the request of the undersigned, are not assuming, nor
is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 or Regulation
13D-G of the Securities Exchange Act of 1934,
as amended. The undersigned hereby agrees to indemnify the attorneys-
in-fact and the Company from and against any
demand, damage, loss, cost or expense arising from any false or
misleading information provided by the undersigned to
the attorneys-in-fact.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file
such forms with respect to the undersigned's holdings of and transactions
in securities issued by the Company, unless
earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact. This Power of
Attorney supersedes any prior power of attorney in connection with the
undersigned's capacity as an officer and/or
director of the Company. This Power of Attorney shall expire as to any
individual attorney-in-fact if such attorney-in-
fact ceases to be an employee of the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of
November ___, 2022.
Signature
Raju Kucherlapati
Print Name